Fmr LLC Aquestive Therapeutics, Inc. Transaction History
Fmr LLC
- $1.68 Trillion
- Q2 2025
A detailed history of Fmr LLC transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 2,330 shares of AQST stock, worth $16,030. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,330
Previous 2,347
0.72%
Holding current value
$16,030
Previous $6,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding AQST
# of Institutions
127Shares Held
47.4MCall Options Held
64.2KPut Options Held
204K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$67.5 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.45MShares$37.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.33MShares$29.8 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.98MShares$20.5 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY2.19MShares$15.1 Million0.32% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $367M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...